Photo of Jeff Gold, M.D.

Jeff Gold M.D.

    • Professor of Medicine, Division of Pulmonary and Critical Care Medicine School of Medicine
    • Molecular Microbiology and Immunology Graduate Program School of Medicine
    • Program in Molecular and Cellular Biosciences School of Medicine

Dr. Gold's main research focus is investigating the role of costimulatory molecules in the innate immune response during polymicrobial sepsis. The lab has previously described an essential role for the costimualtory receptor, CD40, in controlling inflammation in murine polymicrobial sepsis. Currently, the lab will be focusing on the effect of simultaneous inhibition of CD40 and CD80/86 in murine polymicrobial sepsis. This will be done in concert with human trials characterizing the expression profiles of costimualtory receptor and their soluble ligands in humans with sepsis. Clinically, aside from the treatment of sepsis, Dr. Gold is extremely interested in new protocols for the management of alcohol withdrawal and delirium tremens in the ICU.

Education

  • M.D., New York University School of Medicine, New York New York 1995
  • Residency:

    • Internal medicine, Columbia Presbyterian Medical Center, 1995
  • Fellowship:

    • Pulmonary and critical care medicine, NYU Medical Center, NY 1998
  • Certifications:

    • American Board of Internal Medicine, internal medicine, 1998

Memberships and associations

  • American Foundation for Medical Research

Publications

  • "Rapid onset of hypoxemia in a man with graft-versus-host disease after stem cell transplant leukemia." Annals of the American Thoracic Society In: , Vol. 14, No. 2, 01.02.2017, p. 283-287.
  • "Perspectives and uses of the electronic health record among US pediatricians : A national survey." Journal of Ambulatory Care Management In: , Vol. 40, No. 1, 2017, p. 59-68.
  • "Accuracy of Laboratory Data Communication on ICU Daily Rounds Using an Electronic Health Record." Critical Care Medicine In: , 20.09.2016.
  • "Feasibility of utilizing a commercial eye tracker to assess electronic health record use during patient simulation." Health Informatics Journal  In: , Vol. 22, No. 3, 01.09.2016, p. 744-757.
  • "The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis." Journal of Cystic Fibrosis In: , 19.07.2016.
  • "Professional and interprofessional differences in electronic health records use and recognition of safety issues in critically ill patients." Journal of Interprofessional Care In: , 25.06.2016, p. 1-7.
  • "Frequency of Passive EHR Alerts in the ICU : Another Form of Alert Fatigue?" Journal of Patient Safety In: , 22.06.2016.
  • "Use of Electronic Health Record Simulation to Understand the Accuracy of Intern Progress Notes." Journal of graduate medical education In: , Vol. 8, No. 2, 01.05.2016, p. 237-240.
  • "Using Simulations to Improve Electronic Health Record Use, Clinician Training and Patient Safety : Recommendations From A Consensus Conference." AMIA ... Annual Symposium proceedings. AMIA Symposium In: , Vol. 2016, 2016, p. 904-913.
  • "Integrating the Electronic Health Record into high-fidelity interprofessional intensive care unit simulations." Journal of Interprofessional Care  In: , Vol. 29, No. 6, 03.11.2015, p. 562-563.
  • "A comparison of free-standing versus co-located long-term acute care hospitals." PLoS One In: , Vol. 10, No. 10, e139742, 06.10.2015.
  • "Participation in EHR based simulation improves recognition of patient safety issues." BMC Medical Education In: , 21.10.2014, p. 1-8.
  • "Use of simulation to assess electronic health record safety in the intensive care unit : A pilot study." BMJ Open In: , Vol. 3, No. 4, e002549, 2013.
  • "Intermittent mechanical tricuspid valve obstruction recognized by central venous pressure tracing and confirmed by transesophageal echocardiography." Journal of the American College of Cardiology In: , Vol. 60, No. 10, 04.09.2012.
  • "The role of cyclooxygenase-2 in mechanical ventilation-induced lung injury." American Journal of Respiratory Cell and Molecular Biology In: , Vol. 47, No. 3, 09.2012, p. 387-394.
  • "Interleukin 5 is protective during sepsis in an eosinophil-independent manner." American Journal of Respiratory and Critical Care Medicine In: , Vol. 186, No. 3, 01.08.2012, p. 246-254.
  • "The role of eosinophils in non-parasitic infections." Endocrine, Metabolic and Immune Disorders - Drug Targets In: , Vol. 11, No. 2, 06.2011, p. 165-172.
  • "OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis." Journal of Immunology In: , Vol. 185, No. 8, 15.10.2010, p. 4856-4862.
  • "Alcohol withdrawal syndromes in the intensive care unit." Critical Care Medicine In: , Vol. 38, No. SUPPL. 9, 09.2010.
  • "Mouse eosinophils possess potent antibacterial properties in vivo." Infection and Immunity In: , Vol. 77, No. 11, 11.2009, p. 4976-4982.
  • "Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis." PLoS One In: , Vol. 4, No. 8, e6600, 12.08.2009.
  • "Racial variations in the incidence of severe alcohol withdrawal." Journal of Medical Toxicology In: , Vol. 5, No. 1, 2009, p. 8-14.
  • "Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense." Nature Medicine  In: , Vol. 14, No. 9, 09.2008, p. 949-953.
  • "CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis." American Journal of Respiratory and Critical Care Medicine In: , Vol. 177, No. 3, 01.02.2008, p. 301-308.
  • "Gene expression profiles of bronchoalveolar cells in pulmonary TB." Tuberculosis In: , Vol. 88, No. 1, 01.2008, p. 39-51.
  • "Exogenous interferon-α and interferon-γ increase lethality of murine inhalational anthrax." PLoS One In: , Vol. 2, No. 8, e736, 15.08.2007.
  • "Benzodiazepine administration and need for mechanical ventilation in delirium tremens [22]." Critical Care Medicine  In: , Vol. 35, No. 7, 07.2007, p. 1811-1812.
  • "Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis." Journal of Infectious Diseases  In: , Vol. 195, No. 9, 01.05.2007, p. 1303-1310.
  • "A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens." Critical Care Medicine In: , Vol. 35, No. 3, 03.2007, p. 724-730.
  • "Erratum : Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages (Journal of Immunology (2004) 172 (6251-6258))." Journal of Immunology In: , Vol. 177, No. 12, 15.12.2006, p. 8874.

Additional information

Edit profile